In-network psychiatric care provider, Talkiatry, appointed Vanessa Cao as SVP of operations as the company prepares for a national rollout. With more than 10 years of experience in operations, Ms. Cao joins Talkiatry...

Closely-held Labster, a virtual learning platform for students, named Hope Frank as chief marketing officer as part of its continued mission to bring accessible and transformative STEM education (science, technology...

Closely-held cell therapy manufacturer, Cellares, appointed Ezekiel Emanuel, M.D. and Ph.D., to its board of advisors. Dr. Emanuel is a bioethicist and currently vice provost for global initiatives, the Diane and Robert...

Closely-held GeneTether, a genome editing technology company, named Roland Boivin as CEO, Jean Jen as CFO and Peter Sampson, Ph.D., as VP of research and development.  The appointments are intended to further position...

Canaccord Genuity appointed Kyle Mikson as a director, senior equity research analyst covering the life science tools and diagnostics sector.  Mr. Mikson will focus on expanding the firm’s footprint on important...

Closely-held Q32 Bio appointed Adam Cutler as chief financial officer, with responsibility for all aspects of its financial strategy and operations. Mr. Cutler has more than 20 years of experience in corporate finance...

Talkiatry appoints Jared Camins as Chief Technology Officer Closely-held Talkiatry, a leading mental health care provider that connects people with high-quality psychiatric care via telehealth or in-person, appointed...

PharmaJet named Paul LaBarre as VP of global business development to lead business development and commercialization strategies, replacing Melissa Malhame, who transitioned to a strategic advisory role for the company...

Eric Tansky, former managing director in Oppenheimer’s medical technology practice, has joined Accelmed Partners, a private equity firm in HealthTech, as a general partner, and Stephen Rubin, former co-head of...

Doug Kleinberg has joined BTIG’s healthcare investment banking unit as a managing director to focus on investment banking opportunities for corporate clients across biotech, biopharma and pharma.  Mr. Kleinberg has over...

John Boris has joined Roth Capital Partners’ healthcare investment banking team as a managing director. Prior to joining Roth, Mr. Boris was the managing partner of JTB Capital Management, where he invested in private...

Closely-held Ripple Therapeutics named Jonathan Talamo, M.D., an internationally known ophthalmologist, innovator and consultant to the industry with more than 25 years of experience in healthcare, to the board. Dr...